Literature DB >> 843578

The analysis of the two-period repeated measurements crossover design with application to clinical trials.

S Wallenstein, A C Fisher.   

Abstract

The two-period repeated measurements crossover design is often employed in clinical trials. This paper presents a unified approach for the statistical analysis of such a design that clarifies the testing procedures and assumptions employed under different conditions. It is shown how the data may be transformed so that it could be analyzed under the framework of a completely randomized repeated measurements design. Applications are given to a comparative bioavailability trial for attainment of steady state levels and to a clinical trial to compare the effects of two hypolipidemics.

Mesh:

Substances:

Year:  1977        PMID: 843578

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  16 in total

1.  The search for more clinically meaningful research designs: single-patient randomized clinical trials.

Authors:  M S Porta
Journal:  J Gen Intern Med       Date:  1986 Nov-Dec       Impact factor: 5.128

2.  A possible explanation for the absence of anti-anginal properties of transdermal nitroglycerin units: an echocardiographic study.

Authors:  E D Bennett; A L Davis
Journal:  Br J Clin Pharmacol       Date:  1985-04       Impact factor: 4.335

3.  Statistical analysis of bioavailability studies: parametric and nonparametric confidence intervals.

Authors:  V W Steinijans; E Diletti
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

4.  Effect of antral instillation of bile salts on fasting serum gastrin levels.

Authors:  J S Levine; J E Coonan; F Kern
Journal:  Dig Dis Sci       Date:  1980-06       Impact factor: 3.199

5.  Prokinetic effect of AS-4370 on gastric emptying in healthy adults.

Authors:  T Kanaizumi; H Nakano; Y Matsui; H Ishikawa; R Shimizu; S Park; N Kuriya
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

6.  Action of mifentidine on the secretory response to sham feeding and pentagastrin and on serum gastrin in duodenal ulcer patients.

Authors:  G Bianchi Porro; M Lazzaroni; B P Imbimbo; O Sangaletti; C Ghirardosi; S Daniotti
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

7.  Comparative bioavailability of trazodone formulations using stable isotope methodology.

Authors:  R E Gammans; A V Mackenthun; J W Russell
Journal:  Br J Clin Pharmacol       Date:  1984-09       Impact factor: 4.335

8.  Comparison of pharmacokinetic profile of levodopa throughout the day between levodopa/carbidopa/entacapone and levodopa/carbidopa when administered four or five times daily.

Authors:  Mikko Kuoppamäki; Kirsi Korpela; Reijo Marttila; Valtteri Kaasinen; Päivi Hartikainen; Jukka Lyytinen; Seppo Kaakkola; Jutta Hänninen; Eliisa Löyttyniemi; Marita Kailajärvi; Päivi Ruokoniemi; Juha Ellmén
Journal:  Eur J Clin Pharmacol       Date:  2009-02-20       Impact factor: 2.953

9.  Human neuropharmacological findings with oxapadol (MD 720111), a new non-narcotic analgesic.

Authors:  F Boureau; B Laquais; M Vadrot; J C Willer
Journal:  Experientia       Date:  1980-01-15

Review 10.  Design, analysis, and presentation of crossover trials.

Authors:  Edward J Mills; An-Wen Chan; Ping Wu; Andy Vail; Gordon H Guyatt; Douglas G Altman
Journal:  Trials       Date:  2009-04-30       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.